Lucid Diagnostics Announces Proposed Public Offering of Common Stock
Press Releases
Lucid Diagnostics  
April 9, 2025

Lucid Diagnostics Announces Proposed Public Offering of Common Stock

NEW YORK, April 9, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM),

avatar profile Olean Times Herald

Olean Times Herald


Local & Social